Dane Leone

Stock Analyst at Raymond James

(0)
# 3989
Out of 5,244 analysts
128
Total ratings
32.69%
Success rate
-3.09%
Average return
42 Stocks
Name Action Price Target Current % Upside Ratings Updated
Xilio Therapeutics
Maintains: Outperform
6 4
1.27 214.96% 3 Nov 8, 2024
Regenxbio
Reinstates: Outperform
45
7.56 495.24% 2 Feb 21, 2024
Blueprint Medicines
Maintains: Strong Buy
85 100
111.71 -10.48% 9 Dec 22, 2023
Revolution Medicines
Initiates Coverage On: Outperform
30
40.12 -25.22% 1 Nov 16, 2023
bluebird bio
Maintains: Outperform
200 260
8.16 3086.27% 6 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
950
686.69 38.34% 10 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 9
0.32 2712.5% 3 Oct 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
13
2.43 434.98% 5 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
29 46
35.97 27.88% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
69
23.8 189.92% 5 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 8
n/a n/a 5 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
29
4.66 522.32% 2 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 8
2.62 205.34% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 14
8.09 73.05% 5 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
58
20.45 183.62% 4 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 70
31.63 121.31% 3 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 63
45.75 37.7% 2 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Jun 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Apr 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 6
n/a n/a 2 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
46.8 38.89% 3 Oct 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Dec 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
255
274.58 -7.13% 3 Oct 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
n/a
n/a n/a 5 Dec 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
32
5.22 513.03% 2 Sep 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Jul 21, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 3 Jun 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
58
n/a n/a 1 Dec 22, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
n/a n/a 1 Sep 23, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 7, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Sep 5, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Aug 25, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 2 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 15, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Aug 11, 2016